etoposide has been researched along with Allergic Encephalomyelitis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allen, CE; Andreassen, PR; Carroll, KR; Chaturvedi, V; Elfers, EE; Greenberg, JN; Henry, MM; Hermiston, ML; Hildeman, DA; Hogan, SP; Jordan, MB; Joyce, M; Kanter, J; Katz, JD; Ladisch, S; Lakes, N; McNally, JP; Millen, SH; Terrell, CE | 1 |
Elfers, EE; Grunblatt, E; Hildeman, DA; Jordan, MB; Katz, JD; McNally, JP; Terrell, CE | 1 |
2 other study(ies) available for etoposide and Allergic Encephalomyelitis
Article | Year |
---|---|
Manipulating DNA damage-response signaling for the treatment of immune-mediated diseases.
Topics: Animals; Cell Cycle Checkpoints; Disease Models, Animal; DNA Damage; Drug Evaluation, Preclinical; Encephalomyelitis, Autoimmune, Experimental; Etoposide; Humans; Immune System Diseases; Lymphocyte Activation; Lymphohistiocytosis, Hemophagocytic; Mice; Mice, 129 Strain; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Multiple Sclerosis; Proto-Oncogene Proteins c-mdm2; Signal Transduction; T-Lymphocytes; Tumor Suppressor Protein p53 | 2017 |
Eliminating encephalitogenic T cells without undermining protective immunity.
Topics: Animals; Apoptosis; B-Lymphocytes; CD4-Positive T-Lymphocytes; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Etoposide; Female; Immunologic Memory; Lymphocyte Activation; Lymphocyte Depletion; Lymphocytic choriomeningitis virus; Mice; Multiple Sclerosis; Recurrence; T-Lymphocytes | 2014 |